Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T

Coronary Artery Disease

Volumn 22, Issue 8, 2011, Pages 553-558

  Rebeiz, Abdallah G ^a   Tamim, Hani M ^c   Sleiman, Rima M ^a   Abchee, Antoine G ^a   Ibrahim, Zeina ^a   Khoury, Maurice Y ^a   Youhanna, Sonia ^b   Skouri, Hadi N ^a   Alam, Samir E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Angina; angiography; coronary disease; inflammation; plaque

Indexed keywords

MYELOPEROXIDASE; TROPONIN T;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD SAMPLING; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DISEASE SEVERITY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX PAIN; ULCER;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; FEMALE; HUMANS; LEBANON; MALE; MIDDLE AGED; ODDS RATIO; PEROXIDASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TROPONIN T;

EID: 81855166677     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834c5e98     Document Type: Article

References (28)

1. Ornato J. Chest pain emergency centers: improving acute myocardial infarction care. Clin Cardiol 1999; 22:IV3-IV9.
2. Brener S, Topol E. Troponin, embolization, and restoration of microvascular integrity. Eur Heart J 2000; 21:1117-1119. (Pubitemid 30438633)
3. Antman E, Tanasijevic M, Thompson B, Schactman M, Mc Cabe C, Cannon C, et al. Cardiac-specific troponin I levels predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-1349. (Pubitemid 26360452)
4. The ACC/AHA Writing Committee. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary. Circulation 2007; 116:803-877.
5. Pope J, Aufderheide T, Ruthazer R, Woolard R, Feldman J, Beshansky J, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163-1170. (Pubitemid 30211047)
6. Sanchis J, Bodi V, Nunez J, Bertomew-Gonzalez V, Gomez C, Bosh M, et al. New risk score for patients with acute chest pain, non-ST-segment deviation and normal troponin concentrations. JAm Coll Cardiol2005; 46:443-449. (Pubitemid 41040284)
7. Klebanoff S, Hazen S. Antimicrobial activity of myeloperoxidase. Methods Enzymol 1984; 105:399-403. (Pubitemid 14165406)
8. Nichols S, Hazen S. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005; 25:1102-1111. (Pubitemid 40776595)
9. Brennan M, Penn M, Lente FV, Nambi V, Shishehbor M, Aviles R, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med2003; 349:1595-1604. (Pubitemid 37288567)
10. Hamm C, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102:118-122. (Pubitemid 30430562)
11. Rebeiz A, Khoury M, Gharzuddine W, Arnaout M, Sawaya J, Abchee A, et al. Angiographic findings in a series of patients with troponin-negative acute coronary syndromes [Abstract]. Eur Heart J 2005; 26 (Suppl):442.
12. Hazen S, Heinecke J. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997; 99:2075-2081. (Pubitemid 27203762)
13. Eiserich J, Baldus S, Brennan M, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296:2391-2394. (Pubitemid 34734213)
14. Podrez E, Febbraio M, Sheibani N, Schmitt D, Silverstein R, Hajjar D, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 2000; 105:1095-1108. (Pubitemid 30217694)
15. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol2004; 24:1309-1314. (Pubitemid 38880026)
16. Fu X, Kassim S, Parks W, Heinecke J. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001;41279-41287.
17. Buffon A, Biasucci L, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12. (Pubitemid 34728951)
18. Meuwese M, Stroes E, Hazen S, Miert JV, Kuivenhoven J, Schaub R, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. JAm Coll Cardiol 2007; 50:159-165. (Pubitemid 47002189)
19. Heslop C, Frohlich J, Hill J. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010; 55:1102-1109.
20. Mocatta T, Pilbrow A, Cameron V, Senthilmohan R, Frampton C, Richards A, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. JAm Coll Cardiol 2007; 49:1993-2000. (Pubitemid 46734639)
21. Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark L, et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007; 99:1364-1368. (Pubitemid 46686633)
22. Baldus S, Heeschen C, Meinertz T, Zeiher A, Eiserich J, Münzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108:1440-1445. (Pubitemid 37176448)
23. Jurlander B, Farhi E, Banas JJ Jr, Keany C, Balu D, Grande P, et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol 2000; 85:810-814. (Pubitemid 30157844)
24. Wainstein R, Wainstein M, Ribeiro J, Dornelles L,Tozzati P, Ashton-Prolla P, et al. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease. Clin Biochem 2010; 43:57-62.
25. Kubala L, Lu G, Baldus S, Berglund L, Eiserich J. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta 2008; 394:59-62.
26. Lucio E, Gonçalves S, Ribeiro J, Nunes G, Oliveira JD, Araujo G, et al. Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome. Inflamm Res 2011; 60:137-142.
27. Naruko T, Furukawa A, Yunoki K, Komatsu R, Nakagawa M, Matsumura Y, etal. Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina. Heart 2010; 96:1716-1722.
28. Ambrose J, Winters S, Stern A, Eng A, Teichholz L, Gorlin R, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5:609-616. (Pubitemid 15141967)